High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer

Journal of Immunology

Volumn 191, Issue 4, 2013, Pages 2001-2008

  Martinet, Ludovic ^a,b,c   Filleron, Thomas ^c   Le Guellec, Sophie ^c   Rochaix, Philippe ^c   Garrido, Ignacio ^a,b,c,d   Girard, Jean Philippe ^a,b,e  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d CHU RANGUEIL   (France)

^e UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN BETA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN;

ARTICLE; B LYMPHOCYTE; BREAST CANCER; CANCER GROWTH; CELL DENSITY; CLUSTER ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RETROSPECTIVE STUDY; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; VASCULAR ENDOTHELIUM;

B-LYMPHOCYTE SUBSETS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DENDRITIC CELLS; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOTOXIN-BETA; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 3; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; RETROSPECTIVE STUDIES; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME; TUMOR MICROENVIRONMENT; VENULES;

EID: 84881421259     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300872     Document Type: Article

References (29)

1. Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature 438: 932-936.
2. Carmeliet, P., and R. K. Jain. 2000. Angiogenesis in cancer and other diseases. Nature 407: 249-257.
3. Martinet, L., I. Garrido, T. Filleron, S. Le Guellec, E. Bellard, J. J. Fournie, P. Rochaix, and J. P. Girard. 2011. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res. 71: 5678-5687.
4. Girard, J. P., C. Moussion, and R. Förster. 2012. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat. Rev. Immunol. 12: 762-773.
5. von Andrian, U. H., and T. R. Mempel. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3: 867-878.
6. Miyasaka, M., and T. Tanaka. 2004. Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat. Rev. Immunol. 4: 360-370.
7. Martinet, L., S. Le Guellec, T. Filleron, L. Lamant, N. Meyer, P. Rochaix, I. Garrido, and J. P. Girard. 2012. High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes. OncoImmunology 1: 829-839.
8. Martinet, L., I. Garrido, and J. P. Girard. 2012. Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancer. OncoImmunology 1: 789-790.
9. Fridman, W. H., J. Galon, F. Pagès, E. Tartour, C. Sautès-Fridman, and G. Kroemer. 2011. Prognostic and predictive impact of intra- and peritumoral immune infiltrates. Cancer Res. 71: 5601-5605.
10. de Chaisemartin, L., J. Goc, D. Damotte, P. Validire, P. Magdeleinat, M. Alifano, I. Cremer, W. H. Fridman, C. Sautès-Fridman, and M. C. Dieu-Nosjean. 2011. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer. Cancer Res. 71: 6391-6399.
11. Cipponi, A., M. Mercier, T. Seremet, J. F. Baurain, I. Théate, J. van den Oord, M. Stas, T. Boon, P. G. Coulie, and N. van Baren. 2012. Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. Cancer Res. 72: 3997-4007.
12. Schrama, D., P. thor Straten, W. H. Fischer, A. D. McLellan, E. B. Bröcker, R. A. Reisfeld, and J. C. Becker. 2001. Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 14: 111-121.
13. Schrama, D., H. Voigt, A. O. Eggert, R. Xiang, H. Zhou, T. N. Schumacher, M. H. Andersen, P. thor Straten, R. A. Reisfeld, and J. C. Becker. 2008. Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue. Cancer Immunol. Immunother. 57: 85-95.
14. Hindley, J. P., E. Jones, K. Smart, H. Bridgeman, S. N. Lauder, B. Ondondo, S. Cutting, K. Ladell, K. K. Wynn, D. Withers, et al. 2012. T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion. Cancer Res. 72: 5473-5482.
15. Moussion, C., and J. P. Girard. 2011. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 479: 542-546.
16. Browning, J. L., N. Allaire, A. Ngam-Ek, E. Notidis, J. Hunt, S. Perrin, and R. A. Fava. 2005. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity 23: 539-550.
17. Liao, S., and N. H. Ruddle. 2006. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J. Immunol. 177: 3369-3379.
18. Drayton, D. L., X. Ying, J. Lee, W. Lesslauer, and N. H. Ruddle. 2003. Ectopic LT alpha beta directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J. Exp. Med. 197: 1153-1163.
19. Drayton, D. L., S. Liao, R. H. Mounzer, and N. H. Ruddle. 2006. Lymphoid organ development: from ontogeny to neogenesis. Nat. Immunol. 7: 344-353.
20. Marinkovic, T., A. Garin, Y. Yokota, Y. X. Fu, N. H. Ruddle, G. C. Furtado, and S. A. Lira. 2006. Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J. Clin. Invest. 116: 2622-2632.
21. Webster, B., E. H. Ekland, L. M. Agle, S. Chyou, R. Ruggieri, and T. T. Lu. 2006. Regulation of lymph node vascular growth by dendritic cells. J. Exp. Med. 203: 1903-1913.
22. -/- mice. J. Exp. Med. 206: 233-248.
23. Motallebzadeh, R., S. Rehakova, T. M. Conlon, T. S. Win, C. J. Callaghan, M. Goddard, E. M. Bolton, N. H. Ruddle, J. A. Bradley, and G. J. Pettigrew. 2012. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. FASEB J. 26: 51-62.
24. Galon, J., A. Costes, F. Sanchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce-Pagès, M. Tosolini, M. Camus, A. Berger, P. Wind, et al. 2006. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960-1964.
25. Pagès, F., A. Kirilovsky, B. Mlecnik, M. Asslaber, M. Tosolini, G. Bindea, C. Lagorce, P. Wind, F. Marliot, P. Bruneval, et al. 2009. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J. Clin. Oncol. 27: 5944-5951.
26. Cyster, J. G. 2005. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23: 127-159.
27. Förster, R., A. C. Davalos-Misslitz, and A. Rot. 2008. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8: 362-371.
28. Yu, P., Y. Lee, W. Liu, R. K. Chin, J. Wang, Y. Wang, A. Schietinger, M. Philip, H. Schreiber, and Y. X. Fu. 2004. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat. Immunol. 5: 141-149.
29. Yu, P., Y. Lee, Y. Wang, X. Liu, S. Auh, T. F. Gajewski, H. Schreiber, Z. You, C. Kaynor, X. Wang, and Y. X. Fu. 2007. Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases. J. Immunol. 179: 1960-1968.